US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Replimune Group Inc.

9.66

+0.05000.52%

Post-market: 9.660.00000.00%17:49 EST

Volume:1.13M

Turnover:10.85M

Market Cap:757.76M

PE:-2.79

High:9.82

Open:9.60

Low:9.50

Close:9.61

52wk High:14.80

52wk Low:2.68

Shares:78.44M

Float Shares:49.97M

Volume Ratio:0.69

T/O Rate:2.25%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.4678

EPS(LYR):-3.0696

ROE:-96.24%

ROA:-44.83%

PB:2.88

PE(LYR):-3.15

Loading ...

Overview Company News Filings

Replimune upgraded to Outperform from Neutral at Wedbush

Replimune Shares Extend Premarket Gains, Last up 92%

THOMSON REUTERS

Replimune Shares Soar After FDA Accepts Melanoma Treatment Resubmission

BUZZ-Replimune jumps after FDA accepts resubmission for skin cancer drug

Shares of Replimune Group Rise 75.8% Premarket After US FDA Accepts Resubmission for Potential Approval of Skin Cancer Drug

THOMSON REUTERS

Replimune Group Inc: Pdufa Date Set by FDA for Rp1 Is April 10, 2026

THOMSON REUTERS

Replimune Announces FDA Acceptance of Bla Resubmission of Rp1 for the Treatment of Advanced Melanoma

THOMSON REUTERS

FDA Accepts Replimune BLA Resubmission for RP1 in Advanced Melanoma

Replimune announces new ad hoc analysis from IGNYTE phase 2 cohort of RP1

Replimune Reports 44% Response Rate for RP1 Plus Nivolumab in Acral Melanoma Trial

Replimune Group Inc. Releases Study Results on RP1 and Nivolumab Combination in Anti-PD-1 Resistant Tumors

Replimune Group Inc. publishes study on immunotherapy for non-melanoma skin cancer

Replimune Group (REPL) Receives a Hold from Barclays

Class Action Lawsuit Filed Against Replimune Group Inc. for Alleged Securities Fraud

JPMorgan Downgrades Replimune Group to Underweight From Neutral

MT Newswires Live

Analysts Have Conflicting Sentiments on These Healthcare Companies: Nektar Therapeutics (NKTR), Embecta Corporation (EMBC) and Replimune Group (REPL)

J.P. Morgan Remains a Sell on Replimune Group (REPL)

Replimune downgraded to Underweight from Neutral at JPMorgan

Replimune Group (REPL) Gets a Hold from Barclays

Replimune Group Inc : JP Morgan Cuts to Underweight From Neutral

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/REPL/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"REPL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REPL\",,,,,undefined,":{"symbol":"REPL","market":"US","secType":"STK","nameCN":"Replimune Group Inc.","latestPrice":9.66,"timestamp":1766005200000,"preClose":9.61,"halted":0,"volume":1125084,"hourTrading":{"tag":"盘后","latestPrice":9.66,"preClose":9.66,"latestTime":"17:49 EST","volume":71688,"amount":692503.92936,"timestamp":1766011776388},"delay":0,"floatShares":49968589,"shares":78443334,"eps":-3.467754,"marketStatus":"Post-Mkt","change":0.05,"latestTime":"12-17 19:38:31 EST","open":9.6,"high":9.82,"low":9.495,"amount":10846271.04444,"amplitude":0.033819,"askPrice":10.15,"askSize":100,"bidPrice":9.46,"bidSize":7,"shortable":3,"etf":0,"ttmEps":-3.467754,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1766019600000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1532059200000,"exchange":"NASDAQ","adjPreClose":9.61,"preHourTrading":{"tag":"盘前","latestPrice":9.66,"preClose":9.61,"latestTime":"08:00 EST","volume":501,"amount":4830.579876,"timestamp":1765976401243},"postHourTrading":{"tag":"盘后","latestPrice":9.66,"preClose":9.66,"latestTime":"17:49 EST","volume":71688,"amount":692503.92936,"timestamp":1766011776388},"volumeRatio":0.690341,"impliedVol":0.7944,"impliedVolPercentile":0.268},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REPL\",,,,,undefined,":{"symbol":"REPL","floatShares":49968589,"roa":"-44.83%","roe":"-96.24%","lyrEps":-3.069566,"volumeRatio":0.690341,"shares":78443334,"dividePrice":0,"high":9.82,"amplitude":0.033819,"preClose":9.61,"low":9.495,"week52Low":2.68,"pbRate":"2.88","week52High":14.7952,"institutionHeld":0,"latestPrice":9.66,"committee":-0.869159,"eps":-3.467754,"divideRate":0,"volume":1125084,"delay":0,"ttmEps":-3.467754,"open":9.6,"prevYearClose":12.11,"prevWeekClose":10.18,"prevMonthClose":10,"prevQuarterClose":4.19,"fiveDayClose":9.82,"twentyDayClose":8.74,"sixtyDayClose":4.33},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/REPL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-06","symbol":"REPL","fiscalQuarterEnding":"2025/09","expectedEps":-0.87,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.9},{"market":"US","date":"2025-08-07","symbol":"REPL","fiscalQuarterEnding":"2025/06","expectedEps":-0.83,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":-0.95},{"market":"US","date":"2025-05-22","symbol":"REPL","fiscalQuarterEnding":"2025/03","expectedEps":-0.75,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747886400000,"reportTimeType":"pre","actualEps":-0.82},{"market":"US","date":"2025-02-12","symbol":"REPL","fiscalQuarterEnding":"2024/12","expectedEps":-0.7,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739336400000,"reportTimeType":"pre","actualEps":-0.79},{"market":"US","date":"2024-11-12","symbol":"REPL","fiscalQuarterEnding":"2024/09","expectedEps":-0.75,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.68}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"REPL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"REPL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.375,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.375,"analysts":8,"updateTime":1762059600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/REPL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"REPL","date":"2025-12-16","current":-2.785665,"percent":0.824167,"low":-30.108202,"twenty":-13.709401,"median":-6.368208,"eighty":-2.601554,"high":-0.874367,"avg":-8.118652,"sd":6.692467,"marketCap":780511173},"quantilePoints":[{"date":"2020-12-18","current":-26.335592,"twenty":-17.792762,"median":-15.443392,"eighty":-12.942942,"marketCap":1832061822},{"date":"2020-12-24","current":-27.656997,"twenty":-17.833312,"median":-15.458438,"eighty":-12.956155,"marketCap":1923986650},{"date":"2020-12-31","current":-25.205792,"twenty":-17.920221,"median":-15.494801,"eighty":-12.966751,"marketCap":1753466094},{"date":"2021-01-08","current":-28.264843,"twenty":-18.079218,"median":-15.510137,"eighty":-12.974293,"marketCap":1966272070},{"date":"2021-01-15","current":-28.562159,"twenty":-18.261285,"median":-15.518256,"eighty":-12.984598,"marketCap":1986955157},{"date":"2021-01-22","current":-29.288932,"twenty":-18.635844,"median":-15.526131,"eighty":-12.991308,"marketCap":2037513812},{"date":"2021-01-29","current":-25.635248,"twenty":-18.853106,"median":-15.53104,"eighty":-12.994069,"marketCap":1783341663},{"date":"2021-02-05","current":-26.84076,"twenty":-19.504667,"median":-15.567438,"eighty":-13.012644,"marketCap":2017351533},{"date":"2021-02-12","current":-22.819904,"twenty":-21.940848,"median":-15.587711,"eighty":-13.047473,"marketCap":1715143997},{"date":"2021-02-19","current":-23.457055,"twenty":-22.436376,"median":-15.606138,"eighty":-13.066316,"marketCap":1763032268},{"date":"2021-02-26","current":-21.421883,"twenty":-22.436376,"median":-15.622317,"eighty":-13.072547,"marketCap":1610068762},{"date":"2021-03-05","current":-21.842527,"twenty":-22.250798,"median":-15.636738,"eighty":-13.086716,"marketCap":1641684319},{"date":"2021-03-12","current":-21.025984,"twenty":-22.237184,"median":-15.656023,"eighty":-13.114651,"marketCap":1580312943},{"date":"2021-03-19","current":-21.8982,"twenty":-22.080584,"median":-15.667314,"eighty":-13.127516,"marketCap":1645868731},{"date":"2021-03-26","current":-20.512551,"twenty":-22.071406,"median":-15.706391,"eighty":-13.135191,"marketCap":1541723365},{"date":"2021-04-01","current":-19.535174,"twenty":-21.972742,"median":-15.742909,"eighty":-13.178949,"marketCap":1468263687},{"date":"2021-04-09","current":-18.601098,"twenty":-21.919166,"median":-15.779654,"eighty":-13.197111,"marketCap":1398058552},{"date":"2021-04-16","current":-18.533053,"twenty":-21.910845,"median":-15.805723,"eighty":-13.201843,"marketCap":1392944271},{"date":"2021-04-23","current":-19.491873,"twenty":-21.900674,"median":-15.81014,"eighty":-13.203144,"marketCap":1465009145},{"date":"2021-04-30","current":-22.634326,"twenty":-21.910845,"median":-15.823722,"eighty":-13.207951,"marketCap":1701195957},{"date":"2021-05-07","current":-22.170381,"twenty":-21.950473,"median":-15.85094,"eighty":-13.241757,"marketCap":1666325857},{"date":"2021-05-14","current":-21.681693,"twenty":-21.982329,"median":-15.875459,"eighty":-13.250591,"marketCap":1629596018},{"date":"2021-05-21","current":-20.875188,"twenty":-21.982329,"median":-15.901941,"eighty":-13.258245,"marketCap":1688176458},{"date":"2021-05-28","current":-22.460135,"twenty":-22.073242,"median":-15.955897,"eighty":-13.283002,"marketCap":1816351093},{"date":"2021-06-04","current":-18.443015,"twenty":-22.004598,"median":-16.002994,"eighty":-13.28992,"marketCap":1491486656},{"date":"2021-06-11","current":-19.595704,"twenty":-21.95287,"median":-16.012966,"eighty":-13.290718,"marketCap":1584704572},{"date":"2021-06-18","current":-20.402586,"twenty":-21.932997,"median":-16.057318,"eighty":-13.292929,"marketCap":1649957113},{"date":"2021-06-25","current":-22.425554,"twenty":-21.932997,"median":-16.081436,"eighty":-13.298312,"marketCap":1813554555},{"date":"2021-07-02","current":-22.788651,"twenty":-22.105608,"median":-16.100527,"eighty":-13.307038,"marketCap":1842918199},{"date":"2021-07-09","current":-20.212392,"twenty":-22.076913,"median":-16.114408,"eighty":-13.311118,"marketCap":1634576157},{"date":"2021-07-16","current":-18.039574,"twenty":-22.026868,"median":-16.132614,"eighty":-13.319278,"marketCap":1458860385},{"date":"2021-07-23","current":-19.063158,"twenty":-21.955266,"median":-16.139958,"eighty":-13.347051,"marketCap":1541637578},{"date":"2021-07-30","current":-18.912918,"twenty":-21.938023,"median":-16.15228,"eighty":-13.375517,"marketCap":1529487661},{"date":"2021-08-06","current":-16.792794,"twenty":-21.918542,"median":-16.19167,"eighty":-13.387047,"marketCap":1522904883},{"date":"2021-08-13","current":-15.575626,"twenty":-21.911392,"median":-16.205733,"eighty":-13.404574,"marketCap":1412522342},{"date":"2021-08-20","current":-15.560153,"twenty":-21.905623,"median":-16.15308,"eighty":-13.425364,"marketCap":1411119174},{"date":"2021-08-27","current":-16.22547,"twenty":-21.895726,"median":-16.15228,"eighty":-13.431331,"marketCap":1471455393},{"date":"2021-09-03","current":-16.988778,"twenty":-21.874892,"median":-16.19167,"eighty":-13.433519,"marketCap":1540678343},{"date":"2021-09-10","current":-16.514289,"twenty":-21.847873,"median":-16.210444,"eighty":-13.441423,"marketCap":1497647861},{"date":"2021-09-17","current":-16.803109,"twenty":-21.82081,"median":-16.215155,"eighty":-13.475095,"marketCap":1523840328},{"date":"2021-09-24","current":-16.638069,"twenty":-21.723491,"median":-16.238363,"eighty":-13.488815,"marketCap":1508873204},{"date":"2021-10-01","current":-15.240389,"twenty":-21.67427,"median":-16.219027,"eighty":-13.513752,"marketCap":1382120371},{"date":"2021-10-08","current":-15.972753,"twenty":-21.626019,"median":-16.19167,"eighty":-13.533427,"marketCap":1448536985},{"date":"2021-10-15","current":-15.549838,"twenty":-21.540653,"median":-16.15388,"eighty":-13.565594,"marketCap":1410183729},{"date":"2021-10-22","current":-14.961884,"twenty":-21.492962,"median":-16.14312,"eighty":-13.567208,"marketCap":1356863349},{"date":"2021-10-29","current":-15.219759,"twenty":-21.476079,"median":-16.139261,"eighty":-13.574656,"marketCap":1380249481},{"date":"2021-11-05","current":-15.694027,"twenty":-21.451576,"median":-16.135948,"eighty":-13.594071,"marketCap":1568586638},{"date":"2021-11-12","current":-15.689335,"twenty":-21.392191,"median":-16.126343,"eighty":-13.624185,"marketCap":1568117703},{"date":"2021-11-19","current":-16.06937,"twenty":-21.266207,"median":-16.114408,"eighty":-13.633329,"marketCap":1606101416},{"date":"2021-11-26","current":-13.606182,"twenty":-21.237353,"median":-16.104262,"eighty":-13.632281,"marketCap":1359910688},{"date":"2021-12-03","current":-12.977483,"twenty":-21.223934,"median":-16.091557,"eighty":-13.587048,"marketCap":1297073435},{"date":"2021-12-10","current":-12.907106,"twenty":-21.205376,"median":-16.076662,"eighty":-13.56612,"marketCap":1290039414},{"date":"2021-12-17","current":-12.311249,"twenty":-21.124959,"median":-16.069894,"eighty":-13.48331,"marketCap":1230484705},{"date":"2021-12-23","current":-13.517038,"twenty":-21.122485,"median":-16.044742,"eighty":-13.433519,"marketCap":1351000928},{"date":"2021-12-31","current":-12.714743,"twenty":-21.069904,"median":-16.015764,"eighty":-13.41643,"marketCap":1270813091},{"date":"2022-01-07","current":-12.189262,"twenty":-21.03217,"median":-16.010593,"eighty":-13.380684,"marketCap":1218292402},{"date":"2022-01-14","current":-11.199295,"twenty":-21.025984,"median":-15.986212,"eighty":-13.311118,"marketCap":1119347176},{"date":"2022-01-21","current":-9.74015,"twenty":-21.006293,"median":-15.955897,"eighty":-13.293375,"marketCap":973508478},{"date":"2022-01-28","current":-8.731415,"twenty":-20.94976,"median":-15.905705,"eighty":-13.286213,"marketCap":872687513},{"date":"2022-02-04","current":-7.99328,"twenty":-20.910732,"median":-15.895098,"eighty":-13.233597,"marketCap":861987330},{"date":"2022-02-11","current":-7.673724,"twenty":-20.897089,"median":-15.869823,"eighty":-13.195305,"marketCap":827526719},{"date":"2022-02-18","current":-7.047744,"twenty":-20.882104,"median":-15.845206,"eighty":-13.132121,"marketCap":760021687},{"date":"2022-02-25","current":-7.183446,"twenty":-20.847524,"median":-15.829866,"eighty":-13.09789,"marketCap":774655645},{"date":"2022-03-04","current":-6.728188,"twenty":-20.805093,"median":-15.823685,"eighty":-13.048554,"marketCap":725561076},{"date":"2022-03-11","current":-7.157181,"twenty":-20.790794,"median":-15.81014,"eighty":-12.996831,"marketCap":771823266},{"date":"2022-03-18","current":-7.179069,"twenty":-20.744594,"median":-15.804542,"eighty":-12.973236,"marketCap":774183582},{"date":"2022-03-25","current":-6.999592,"twenty":-20.701197,"median":-15.776661,"eighty":-12.940996,"marketCap":754828992},{"date":"2022-04-01","current":-7.99328,"twenty":-20.631971,"median":-15.738739,"eighty":-12.832728,"marketCap":861987330},{"date":"2022-04-08","current":-8.5142,"twenty":-20.531056,"median":-15.706391,"eighty":-12.758307,"marketCap":918162846},{"date":"2022-04-14","current":-7.774406,"twenty":-20.522449,"median":-15.696716,"eighty":-12.748252,"marketCap":838384172},{"date":"2022-04-22","current":-8.01079,"twenty":-20.493993,"median":-15.689335,"eighty":-12.730018,"marketCap":863875582},{"date":"2022-04-29","current":-7.341035,"twenty":-20.416327,"median":-15.662226,"eighty":-12.654887,"marketCap":791649919},{"date":"2022-05-06","current":-6.452407,"twenty":-20.38299,"median":-15.655671,"eighty":-12.538835,"marketCap":695821097},{"date":"2022-05-13","current":-6.491804,"twenty":-20.292997,"median":-15.6402,"eighty":-12.449348,"marketCap":700069666},{"date":"2022-05-20","current":-6.148507,"twenty":-20.245319,"median":-15.637726,"eighty":-12.395603,"marketCap":725745226},{"date":"2022-05-27","current":-6.235809,"twenty":-20.234774,"median":-15.631638,"eighty":-12.379449,"marketCap":736049925},{"date":"2022-06-03","current":-6.809503,"twenty":-20.212392,"median":-15.622317,"eighty":-12.311955,"marketCap":803766518},{"date":"2022-06-10","current":-6.468612,"twenty":-20.203255,"median":-15.607654,"eighty":-12.134279,"marketCap":763529122},{"date":"2022-06-17","current":-6.318953,"twenty":-20.189959,"median":-15.595469,"eighty":-11.992537,"marketCap":745863924},{"date":"2022-06-24","current":-7.699145,"twenty":-20.143355,"median":-15.58377,"eighty":-11.944204,"marketCap":908776307},{"date":"2022-07-01","current":-7.640944,"twenty":-20.124611,"median":-15.580646,"eighty":-11.881776,"marketCap":901906508},{"date":"2022-07-08","current":-8.79249,"twenty":-20.103951,"median":-15.560153,"eighty":-11.848266,"marketCap":1037830394},{"date":"2022-07-15","current":-8.534744,"twenty":-20.061997,"median":-15.550705,"eighty":-11.726024,"marketCap":1007406997},{"date":"2022-07-22","current":-7.782289,"twenty":-20.016455,"median":-15.527958,"eighty":-11.633525,"marketCap":918590306},{"date":"2022-07-29","current":-8.053709,"twenty":-19.98877,"median":-15.522807,"eighty":-11.543915,"marketCap":950627642},{"date":"2022-08-05","current":-7.601167,"twenty":-19.981078,"median":-15.512904,"eighty":-11.450611,"marketCap":1010788047},{"date":"2022-08-12","current":-7.515886,"twenty":-19.970963,"median":-15.503521,"eighty":-11.34073,"marketCap":999447498},{"date":"2022-08-19","current":-7.145097,"twenty":-19.933441,"median":-15.494489,"eighty":-11.242484,"marketCap":950140764},{"date":"2022-08-26","current":-7.108019,"twenty":-19.888487,"median":-15.449739,"eighty":-11.188671,"marketCap":945210090},{"date":"2022-09-02","current":-6.993074,"twenty":-19.816752,"median":-15.442937,"eighty":-10.953866,"marketCap":929925003},{"date":"2022-09-09","current":-6.80768,"twenty":-19.756813,"median":-15.436976,"eighty":-10.890541,"marketCap":905271636},{"date":"2022-09-16","current":-6.110597,"twenty":-19.689634,"median":-15.431329,"eighty":-10.778331,"marketCap":812574976},{"date":"2022-09-23","current":-5.888124,"twenty":-19.622483,"median":-15.403136,"eighty":-10.685646,"marketCap":782990935},{"date":"2022-09-30","current":-6.40352,"twenty":-19.571492,"median":-15.3916,"eighty":-10.533097,"marketCap":851527296},{"date":"2022-10-07","current":-6.407228,"twenty":-19.534008,"median":-15.373891,"eighty":-10.386415,"marketCap":852020363},{"date":"2022-10-14","current":-6.918916,"twenty":-19.530951,"median":-15.351275,"eighty":-10.014098,"marketCap":920063656},{"date":"2022-10-21","current":-7.104311,"twenty":-19.514142,"median":-15.301721,"eighty":-9.807604,"marketCap":944717023},{"date":"2022-10-28","current":-6.700151,"twenty":-19.463693,"median":-15.295377,"eighty":-9.668193,"marketCap":890972683},{"date":"2022-11-04","current":-6.285013,"twenty":-19.412753,"median":-15.286558,"eighty":-9.346952,"marketCap":922168605},{"date":"2022-11-11","current":-7.118947,"twenty":-19.397565,"median":-15.277234,"eighty":-9.233032,"marketCap":1044527547},{"date":"2022-11-18","current":-6.451122,"twenty":-19.391261,"median":-15.249135,"eighty":-9.01396,"marketCap":946540915},{"date":"2022-11-25","current":-6.77656,"twenty":-19.371343,"median":-15.242339,"eighty":-8.798362,"marketCap":994290745},{"date":"2022-12-02","current":-6.888429,"twenty":-19.304205,"median":-15.235232,"eighty":-8.708895,"marketCap":1010704750},{"date":"2022-12-09","current":-9.390679,"twenty":-19.279831,"median":-15.219759,"eighty":-8.63141,"marketCap":1377847325},{"date":"2022-12-16","current":-10.475589,"twenty":-19.272597,"median":-15.211631,"eighty":-8.66615,"marketCap":1537030766},{"date":"2022-12-23","current":-10.317569,"twenty":-19.263359,"median":-15.167534,"eighty":-8.683543,"marketCap":1513845240},{"date":"2022-12-30","current":-10.483297,"twenty":-19.232063,"median":-15.140954,"eighty":-8.703265,"marketCap":1538161768},{"date":"2023-01-06","current":-9.951424,"twenty":-19.172861,"median":-15.102526,"eighty":-8.725785,"marketCap":1460122678},{"date":"2023-01-13","current":-10.814754,"twenty":-19.157758,"median":-15.094278,"eighty":-8.739746,"marketCap":1586794823},{"date":"2023-01-20","current":-10.571943,"twenty":-19.139105,"median":-15.069399,"eighty":-8.744456,"marketCap":1551168282},{"date":"2023-01-27","current":-9.978403,"twenty":-19.098984,"median":-15.054481,"eighty":-8.773977,"marketCap":1464081182},{"date":"2023-02-03","current":-10.9034,"twenty":-19.078394,"median":-15.010475,"eighty":-8.810107,"marketCap":1599801338},{"date":"2023-02-10","current":-9.011098,"twenty":-19.073536,"median":-14.978305,"eighty":-8.917906,"marketCap":1412408501},{"date":"2023-02-17","current":-8.971338,"twenty":-19.066387,"median":-14.977232,"eighty":-8.826962,"marketCap":1406176454},{"date":"2023-02-24","current":-7.156829,"twenty":-19.047944,"median":-14.961884,"eighty":-8.755293,"marketCap":1121768485},{"date":"2023-03-03","current":-7.96649,"twenty":-18.994109,"median":-14.946412,"eighty":-8.688473,"marketCap":1248675626},{"date":"2023-03-10","current":-6.741154,"twenty":-18.947558,"median":-14.924413,"eighty":-8.617499,"marketCap":1056615265},{"date":"2023-03-17","current":-7.084537,"twenty":-18.937613,"median":-14.892132,"eighty":-8.574334,"marketCap":1110437490},{"date":"2023-03-24","current":-7.1496,"twenty":-18.918827,"median":-14.820632,"eighty":-8.464903,"marketCap":1120635385},{"date":"2023-03-31","current":-6.383313,"twenty":-18.90696,"median":-14.796136,"eighty":-8.404346,"marketCap":1000526840},{"date":"2023-04-06","current":-5.967638,"twenty":-18.893903,"median":-14.769731,"eighty":-8.353404,"marketCap":935373620},{"date":"2023-04-14","current":-5.880889,"twenty":-18.876593,"median":-14.754647,"eighty":-8.240934,"marketCap":921776426},{"date":"2023-04-21","current":-6.014628,"twenty":-18.872042,"median":-14.72342,"eighty":-8.237923,"marketCap":942738767},{"date":"2023-04-28","current":-6.058002,"twenty":-18.865271,"median":-14.673543,"eighty":-8.162132,"marketCap":949537364},{"date":"2023-05-05","current":-6.307407,"twenty":-18.84001,"median":-14.642657,"eighty":-8.111975,"marketCap":988629296},{"date":"2023-05-12","current":-6.773685,"twenty":-18.786092,"median":-14.624593,"eighty":-8.085208,"marketCap":1061714212},{"date":"2023-05-18","current":-6.338918,"twenty":-18.760756,"median":-14.598129,"eighty":-8.043545,"marketCap":1104771993},{"date":"2023-05-26","current":-6.368208,"twenty":-18.750284,"median":-14.595028,"eighty":-8.000284,"marketCap":1109876825},{"date":"2023-06-02","current":-6.12621,"twenty":-18.73441,"median":-14.58914,"eighty":-7.976597,"marketCap":1067700350},{"date":"2023-06-09","current":-7.47875,"twenty":-18.702219,"median":-14.527689,"eighty":-7.936373,"marketCap":1303426402},{"date":"2023-06-16","current":-7.962747,"twenty":-18.69597,"median":-14.518235,"eighty":-7.928773,"marketCap":1387779351},{"date":"2023-06-23","current":-7.796994,"twenty":-18.685243,"median":-14.453528,"eighty":-7.888232,"marketCap":1358891355},{"date":"2023-06-30","current":-7.661077,"twenty":-18.667244,"median":-14.399755,"eighty":-7.855942,"marketCap":1335203198},{"date":"2023-07-07","current":-7.004698,"twenty":-18.652142,"median":-14.394793,"eighty":-7.843896,"marketCap":1220806732},{"date":"2023-07-14","current":-6.78922,"twenty":-18.6103,"median":-14.376721,"eighty":-7.822971,"marketCap":1183252336},{"date":"2023-07-21","current":-6.80248,"twenty":-18.564048,"median":-14.344533,"eighty":-7.779136,"marketCap":1185563376},{"date":"2023-07-28","current":-6.594113,"twenty":-18.408435,"median":-14.24963,"eighty":-7.705572,"marketCap":1149248430},{"date":"2023-08-04","current":-6.255847,"twenty":-18.227267,"median":-14.198296,"eighty":-7.665176,"marketCap":1135974257},{"date":"2023-08-11","current":-6.335446,"twenty":-18.127797,"median":-14.118082,"eighty":-7.647887,"marketCap":1150428357},{"date":"2023-08-18","current":-6.198991,"twenty":-17.947873,"median":-14.068648,"eighty":-7.573533,"marketCap":1125649900},{"date":"2023-08-25","current":-6.6311,"twenty":-17.81854,"median":-14.004724,"eighty":-7.50913,"marketCap":1204115013},{"date":"2023-09-01","current":-6.634349,"twenty":-17.717437,"median":-13.953723,"eighty":-7.465927,"marketCap":1204704976},{"date":"2023-09-08","current":-6.367936,"twenty":-17.631427,"median":-13.917117,"eighty":-7.434714,"marketCap":1156327989},{"date":"2023-09-15","current":-6.013801,"twenty":-17.579267,"median":-13.810922,"eighty":-7.397943,"marketCap":1092021994},{"date":"2023-09-28","current":-5.393252,"twenty":-17.366758,"median":-13.743606,"eighty":-7.371559,"marketCap":979339011},{"date":"2023-10-06","current":-5.234053,"twenty":-17.358495,"median":-13.711323,"eighty":-7.341615,"marketCap":950430811},{"date":"2023-10-13","current":-4.792197,"twenty":-17.358973,"median":-13.704061,"eighty":-7.315646,"marketCap":870195808},{"date":"2023-10-19","current":-4.649243,"twenty":-17.359211,"median":-13.6531,"eighty":-7.277231,"marketCap":844237425},{"date":"2023-10-23","current":-4.821437,"twenty":-17.35945,"median":-13.643461,"eighty":-7.266629,"marketCap":875505477},{"date":"2023-10-31","current":-4.6265,"twenty":-17.364158,"median":-13.606182,"eighty":-7.244347,"marketCap":840107682},{"date":"2023-11-10","current":-3.415142,"twenty":-17.32282,"median":-13.521228,"eighty":-7.181695,"marketCap":678001257},{"date":"2023-11-17","current":-3.070058,"twenty":-17.327339,"median":-13.433519,"eighty":-7.15697,"marketCap":609492419},{"date":"2023-11-24","current":-3.090882,"twenty":-17.327339,"median":-13.422358,"eighty":-7.134315,"marketCap":613626573},{"date":"2023-12-01","current":-3.325896,"twenty":-17.327339,"median":-13.311118,"eighty":-7.115651,"marketCap":660283454},{"date":"2023-12-08","current":-2.260895,"twenty":-17.32282,"median":-13.291275,"eighty":-7.101345,"marketCap":448851006},{"date":"2023-12-15","current":-2.308493,"twenty":-17.32282,"median":-13.255017,"eighty":-7.080326,"marketCap":458300501},{"date":"2023-12-22","current":-2.290644,"twenty":-17.32282,"median":-13.177521,"eighty":-7.039837,"marketCap":454756941},{"date":"2023-12-29","current":-2.555407,"twenty":-17.327339,"median":-13.141695,"eighty":-7.025096,"marketCap":507319756},{"date":"2024-01-05","current":-2.620854,"twenty":-17.331857,"median":-13.153424,"eighty":-7.015385,"marketCap":520312811},{"date":"2024-01-12","current":-2.620854,"twenty":-17.331857,"median":-13.153424,"eighty":-6.998149,"marketCap":520312811},{"date":"2024-01-19","current":-2.27577,"twenty":-17.336375,"median":-13.165154,"eighty":-6.976101,"marketCap":451803973},{"date":"2024-01-26","current":-2.347166,"twenty":-17.331857,"median":-13.153424,"eighty":-6.953227,"marketCap":465978216},{"date":"2024-02-02","current":-2.338242,"twenty":-17.331857,"median":-13.131353,"eighty":-6.92926,"marketCap":464206435},{"date":"2024-02-09","current":-2.257183,"twenty":-17.331857,"median":-13.069432,"eighty":-6.885152,"marketCap":473913707},{"date":"2024-02-16","current":-2.23964,"twenty":-17.304882,"median":-13.00772,"eighty":-6.857169,"marketCap":470230440},{"date":"2024-02-23","current":-2.324431,"twenty":-17.304882,"median":-12.978804,"eighty":-6.834348,"marketCap":488032898},{"date":"2024-03-01","current":-2.508631,"twenty":-17.29598,"median":-12.943915,"eighty":-6.80768,"marketCap":526707203},{"date":"2024-03-08","current":-2.58465,"twenty":-17.29598,"median":-12.874263,"eighty":-6.789321,"marketCap":542668028},{"date":"2024-03-15","current":-2.58465,"twenty":-17.29598,"median":-12.874263,"eighty":-6.773685,"marketCap":542668028},{"date":"2024-03-22","current":-2.397526,"twenty":-17.29598,"median":-12.760313,"eighty":-6.739451,"marketCap":503379845},{"date":"2024-03-28","current":-2.412145,"twenty":-17.29598,"median":-12.747585,"eighty":-6.71682,"marketCap":506449234},{"date":"2024-04-05","current":-2.146078,"twenty":-17.304882,"median":-12.701477,"eighty":-6.680523,"marketCap":450586349},{"date":"2024-04-12","current":-2.102221,"twenty":-17.261345,"median":-12.582004,"eighty":-6.649243,"marketCap":441378181},{"date":"2024-04-19","current":-2.037897,"twenty":-17.261345,"median":-12.418128,"eighty":-6.619319,"marketCap":427872868},{"date":"2024-04-26","current":-1.798145,"twenty":-17.253415,"median":-12.311955,"eighty":-6.599292,"marketCap":377534883},{"date":"2024-05-03","current":-1.918021,"twenty":-17.253415,"median":-12.073728,"eighty":-6.568396,"marketCap":402703876},{"date":"2024-05-10","current":-1.967726,"twenty":-17.253415,"median":-11.686636,"eighty":-6.523016,"marketCap":413139799},{"date":"2024-05-17","current":-1.912516,"twenty":-17.253415,"median":-11.471468,"eighty":-6.489603,"marketCap":412709505},{"date":"2024-05-24","current":-1.610839,"twenty":-17.253415,"median":-11.245895,"eighty":-6.455856,"marketCap":347609494},{"date":"2024-05-31","current":-1.451463,"twenty":-17.253415,"median":-11.199295,"eighty":-6.429551,"marketCap":313217035},{"date":"2024-06-07","current":-2.02351,"twenty":-17.253415,"median":-11.019024,"eighty":-6.403667,"marketCap":436661396},{"date":"2024-06-14","current":-2.692322,"twenty":-17.261345,"median":-10.931572,"eighty":-6.396942,"marketCap":580986893},{"date":"2024-06-21","current":-2.239807,"twenty":-17.269275,"median":-10.852478,"eighty":-6.368208,"marketCap":483336876},{"date":"2024-06-28","current":-2.424797,"twenty":-17.29598,"median":-10.804126,"eighty":-6.362258,"marketCap":523256694},{"date":"2024-07-05","current":-2.302419,"twenty":-17.29598,"median":-10.763984,"eighty":-6.338722,"marketCap":496848199},{"date":"2024-07-12","current":-2.823238,"twenty":-17.29598,"median":-10.704911,"eighty":-6.326195,"marketCap":609237841},{"date":"2024-07-15","current":-2.948462,"twenty":-17.29598,"median":-10.672408,"eighty":-6.321564,"marketCap":636260487},{"date":"2024-08-02","current":-3.2357,"twenty":-17.360806,"median":-10.556526,"eighty":-6.30697,"marketCap":698244667},{"date":"2024-08-09","current":-2.934568,"twenty":-17.360806,"median":-10.481741,"eighty":-6.280817,"marketCap":645637192},{"date":"2024-08-16","current":-3.198524,"twenty":-17.360806,"median":-10.336007,"eighty":-6.231015,"marketCap":703710378},{"date":"2024-08-23","current":-3.148838,"twenty":-17.360806,"median":-10.221215,"eighty":-6.160784,"marketCap":692778955},{"date":"2024-08-30","current":-3.434531,"twenty":-17.360806,"median":-10.111004,"eighty":-6.142122,"marketCap":755634639},{"date":"2024-09-06","current":-3.328949,"twenty":-17.360806,"median":-10.055486,"eighty":-6.110199,"marketCap":732405365},{"date":"2024-09-13","current":-3.223367,"twenty":-17.360806,"median":-9.951424,"eighty":-6.072015,"marketCap":709176090},{"date":"2024-09-20","current":-3.487322,"twenty":-17.360806,"median":-9.824237,"eighty":-6.050554,"marketCap":767249277},{"date":"2024-09-27","current":-3.456269,"twenty":-17.341038,"median":-9.672861,"eighty":-6.031978,"marketCap":760417137},{"date":"2024-10-04","current":-3.630169,"twenty":-17.341038,"median":-9.390679,"eighty":-5.972448,"marketCap":798677119},{"date":"2024-10-11","current":-3.453163,"twenty":-17.341038,"median":-9.226291,"eighty":-5.909884,"marketCap":759733923},{"date":"2024-10-18","current":-3.512165,"twenty":-17.341038,"median":-9.011098,"eighty":-5.876626,"marketCap":772714988},{"date":"2024-10-25","current":-3.714014,"twenty":-17.341038,"median":-8.90989,"eighty":-5.795064,"marketCap":817123896},{"date":"2024-10-31","current":-3.760594,"twenty":-17.341038,"median":-8.768922,"eighty":-5.525809,"marketCap":827372105},{"date":"2024-11-08","current":-3.791648,"twenty":-17.205109,"median":-8.678585,"eighty":-5.069007,"marketCap":834204245},{"date":"2024-11-15","current":-3.661401,"twenty":-17.192664,"median":-8.604536,"eighty":-4.715521,"marketCap":779958861},{"date":"2024-11-22","current":-3.548989,"twenty":-17.192664,"median":-8.493293,"eighty":-3.820091,"marketCap":756012756},{"date":"2024-11-29","current":-4.522151,"twenty":-17.192664,"median":-8.424021,"eighty":-3.820091,"marketCap":963317611},{"date":"2024-12-06","current":-4.615452,"twenty":-17.192664,"median":-8.333153,"eighty":-3.820091,"marketCap":983192794},{"date":"2024-12-13","current":-4.321902,"twenty":-17.192664,"median":-8.240025,"eighty":-3.820091,"marketCap":920660225},{"date":"2024-12-20","current":-4.24763,"twenty":-17.192664,"median":-8.201035,"eighty":-3.820091,"marketCap":904838732},{"date":"2024-12-27","current":-4.523497,"twenty":-17.192664,"median":-8.13773,"eighty":-3.820091,"marketCap":963604278},{"date":"2025-01-03","current":-4.537396,"twenty":-17.192664,"median":-8.078641,"eighty":-3.820091,"marketCap":966565111},{"date":"2025-01-10","current":-4.1653,"twenty":-17.196713,"median":-8.023922,"eighty":-3.817856,"marketCap":887300616},{"date":"2025-01-17","current":-3.742629,"twenty":-17.078146,"median":-7.988903,"eighty":-3.790414,"marketCap":797262305},{"date":"2025-01-24","current":-4.967292,"twenty":-16.990879,"median":-7.962747,"eighty":-3.774419,"marketCap":1058142538},{"date":"2025-01-31","current":-4.920329,"twenty":-16.953236,"median":-7.899761,"eighty":-3.774419,"marketCap":1048138282},{"date":"2025-02-07","current":-5.079282,"twenty":-16.830086,"median":-7.844848,"eighty":-3.774419,"marketCap":1081998843},{"date":"2025-02-14","current":-4.821817,"twenty":-16.78929,"median":-7.805048,"eighty":-3.774419,"marketCap":1100541220},{"date":"2025-02-21","current":-4.828566,"twenty":-16.78929,"median":-7.774406,"eighty":-3.774419,"marketCap":1102081516},{"date":"2025-02-28","current":-4.263377,"twenty":-16.78929,"median":-7.699145,"eighty":-3.774419,"marketCap":973081757},{"date":"2025-03-07","current":-3.961381,"twenty":-16.791042,"median":-7.658931,"eighty":-3.769362,"marketCap":904153528},{"date":"2025-03-14","current":-4.001872,"twenty":-16.791042,"median":-7.643303,"eighty":-3.761336,"marketCap":913395302},{"date":"2025-03-21","current":-3.914141,"twenty":-16.791042,"median":-7.573195,"eighty":-3.761336,"marketCap":893371459},{"date":"2025-03-28","current":-3.526102,"twenty":-16.791042,"median":-7.503948,"eighty":-3.734509,"marketCap":804804461},{"date":"2025-04-04","current":-2.662291,"twenty":-16.791042,"median":-7.445715,"eighty":-3.714635,"marketCap":607646622},{"date":"2025-04-11","current":-2.334988,"twenty":-16.78929,"median":-7.411075,"eighty":-3.662101,"marketCap":532942284},{"date":"2025-04-17","current":-2.57456,"twenty":-16.78929,"median":-7.377317,"eighty":-3.643832,"marketCap":587622779},{"date":"2025-04-25","current":-3.057079,"twenty":-16.791042,"median":-7.330201,"eighty":-3.582346,"marketCap":697753915},{"date":"2025-05-02","current":-3.252786,"twenty":-16.791042,"median":-7.279839,"eighty":-3.541256,"marketCap":742422488},{"date":"2025-05-09","current":-2.6218,"twenty":-16.791042,"median":-7.234737,"eighty":-3.513106,"marketCap":598404848},{"date":"2025-05-16","current":-2.43959,"twenty":-16.777387,"median":-7.178793,"eighty":-3.476302,"marketCap":556816866},{"date":"2025-05-23","current":-2.730643,"twenty":-16.657668,"median":-7.147348,"eighty":-3.456269,"marketCap":675279930},{"date":"2025-05-30","current":-2.920791,"twenty":-16.652724,"median":-7.131505,"eighty":-3.437637,"marketCap":722302847},{"date":"2025-06-06","current":-3.039244,"twenty":-16.636006,"median":-7.108524,"eighty":-3.417157,"marketCap":751595812},{"date":"2025-06-13","current":-3.081325,"twenty":-16.625774,"median":-7.092688,"eighty":-3.377634,"marketCap":762002523},{"date":"2025-06-20","current":-2.958197,"twenty":-16.627754,"median":-7.067232,"eighty":-3.325896,"marketCap":731553257},{"date":"2025-06-27","current":-2.948846,"twenty":-16.544737,"median":-7.037548,"eighty":-3.285474,"marketCap":729240655},{"date":"2025-07-03","current":-2.930143,"twenty":-16.498817,"median":-7.021479,"eighty":-3.248209,"marketCap":724615450},{"date":"2025-07-11","current":-3.357195,"twenty":-16.442084,"median":-6.999592,"eighty":-3.235625,"marketCap":830224297},{"date":"2025-07-18","current":-3.896466,"twenty":-16.364758,"median":-6.976101,"eighty":-3.235625,"marketCap":963584375},{"date":"2025-07-25","current":-0.966324,"twenty":-16.32862,"median":-6.95293,"eighty":-3.220261,"marketCap":238968925},{"date":"2025-08-01","current":-2.211852,"twenty":-16.32862,"median":-6.926755,"eighty":-3.197708,"marketCap":546984433},{"date":"2025-08-08","current":-1.521613,"twenty":-16.25891,"median":-6.884333,"eighty":-3.189052,"marketCap":426383313},{"date":"2025-08-15","current":-1.490264,"twenty":-16.251257,"median":-6.855232,"eighty":-3.157696,"marketCap":417598776},{"date":"2025-08-22","current":-1.559902,"twenty":-16.251257,"median":-6.81724,"eighty":-3.102781,"marketCap":437112737},{"date":"2025-08-29","current":-1.498621,"twenty":-16.22547,"median":-6.802605,"eighty":-3.090882,"marketCap":419940451},{"date":"2025-09-05","current":-1.618399,"twenty":-16.215929,"median":-6.784969,"eighty":-3.068883,"marketCap":453504465},{"date":"2025-09-12","current":-1.67411,"twenty":-16.132635,"median":-6.773685,"eighty":-3.048595,"marketCap":469115634},{"date":"2025-09-19","current":-0.963797,"twenty":-16.075902,"median":-6.738316,"eighty":-3.021518,"marketCap":270073227},{"date":"2025-09-26","current":-1.128144,"twenty":-16.075902,"median":-6.70973,"eighty":-2.979471,"marketCap":316126176},{"date":"2025-10-03","current":-1.295276,"twenty":-16.070745,"median":-6.676586,"eighty":-2.957539,"marketCap":362959683},{"date":"2025-10-10","current":-1.289705,"twenty":-15.972753,"median":-6.634349,"eighty":-2.934568,"marketCap":361398566},{"date":"2025-10-17","current":-1.300847,"twenty":-15.720035,"median":-6.618272,"eighty":-2.911439,"marketCap":364520800},{"date":"2025-10-24","current":-2.345425,"twenty":-15.642673,"median":-6.590111,"eighty":-2.877151,"marketCap":657230223},{"date":"2025-10-31","current":-2.855179,"twenty":-15.609575,"median":-6.559251,"eighty":-2.844036,"marketCap":800072421},{"date":"2025-11-07","current":-2.138427,"twenty":-15.549838,"median":-6.518465,"eighty":-2.766893,"marketCap":663474691},{"date":"2025-11-14","current":-2.2704,"twenty":-15.403136,"median":-6.4784,"eighty":-2.692322,"marketCap":704421139},{"date":"2025-11-21","current":-2.277985,"twenty":-15.271334,"median":-6.451122,"eighty":-2.648794,"marketCap":706774439},{"date":"2025-11-28","current":-2.561153,"twenty":-15.219759,"median":-6.429475,"eighty":-2.625584,"marketCap":794630973},{"date":"2025-12-05","current":-2.662284,"twenty":-14.946412,"median":-6.40352,"eighty":-2.620854,"marketCap":826008307},{"date":"2025-12-12","current":-2.495417,"twenty":-13.958066,"median":-6.383313,"eighty":-2.604134,"marketCap":774235706},{"date":"2025-12-16","current":-2.515644,"twenty":-13.709401,"median":-6.368208,"eighty":-2.601554,"marketCap":780511173}],"updateTime":1766018311337},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"REPL\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2576852933","title":"Replimune upgraded to Outperform from Neutral at Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2576852933","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576852933?lang=en_us&edition=fundamental","pubTime":"2025-10-20 21:00","pubTimestamp":1760965210,"startTime":"0","endTime":"0","summary":"Wedbush upgraded Replimune (REPL) to Outperform from Neutral with a price target of $18, up from $4. Published first on TheFly – the ultimate sourc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/replimune-upgraded-to-outperform-from-neutral-at-wedbush-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/replimune-upgraded-to-outperform-from-neutral-at-wedbush-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["REPL","BK4139"],"gpt_icon":0},{"id":"2576867854","title":"Replimune Shares Extend Premarket Gains, Last up 92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576867854","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576867854?lang=en_us&edition=fundamental","pubTime":"2025-10-20 20:38","pubTimestamp":1760963923,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nL4N3W10F6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2576856960","title":"Replimune Shares Soar After FDA Accepts Melanoma Treatment Resubmission","url":"https://stock-news.laohu8.com/highlight/detail?id=2576856960","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576856960?lang=en_us&edition=fundamental","pubTime":"2025-10-20 19:39","pubTimestamp":1760960340,"startTime":"0","endTime":"0","summary":"Shares of Replimune soared in premarket trading after the FDA accepted the biotechnology company's resubmission of a biologics license application for its treatment of advanced melanoma.The stock surged 82% to $8.21. The stock was down 63% this year as of Friday's close.The FDA indicated the application resubmission is considered to be a complete response to the letter it sent Replimune in July. The complete response letter had said the agency wouldn't approve the drug, called RP1, saying the company's trial study was inadequate.Replimune said the FDA will now decide whether to approve the drug by April 10, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"26c657bd6894c690b20c7751c141e52e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Replimune Shares Soar After FDA Accepts Melanoma Treatment Resubmission","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2576856320","title":"BUZZ-Replimune jumps after FDA accepts resubmission for skin cancer drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2576856320","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576856320?lang=en_us&edition=fundamental","pubTime":"2025-10-20 19:31","pubTimestamp":1760959869,"startTime":"0","endTime":"0","summary":"BUZZ-Replimune jumps after FDA accepts resubmission for skin cancer drug** Shares of drug developer Replimune Group's REPL.O rise 73.6% to $7.81 premarket** Company says the U.S. FDA has accepted the resubmission of an application for its experimental therapy, RP1, in combination with Bristol Myers Squibb's BMY.N Opdivo for the treatment of advanced melanoma** FDA is set to decide on the drug by April 10** The company received a complete response letter by the FDA in July this year citing insufficient data for substantial evidence of effectiveness** As of last close, stock down 62.8% YTD   ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"26c657bd6894c690b20c7751c141e52e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nL4N3W10BJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","LU0306807586.USD","LU0225771236.USD","LU1261432733.SGD","LU0114720955.EUR","LU2360032135.SGD","IE00BFXG1179.USD","LU0267386448.USD","LU0456855351.SGD","LU1718418525.SGD","REPL","BMY","BK4559","BK4532","LU0061475181.USD","IE0009355771.USD","LU1868837300.USD","LU1032466523.USD","LU1571399168.USD","LU0321505868.SGD","LU1868837136.USD","LU0882574055.USD","LU1323610961.USD","LU1074936037.SGD","LU1670710661.SGD","IE0002141913.USD","BK4585","LU0306806265.USD","BK4139","LU1989771016.USD","LU1585245621.USD","LU1093756168.USD","LU1291159041.SGD","BK4007","BK4588","BK4534","LU0096364046.USD","IE00BSNM7G36.USD","LU1670710588.SGD","LU0225284248.USD","LU0321505439.SGD","LU1868836757.USD","LU1868836914.USD","LU2242652126.USD","LU2125154935.USD","LU1670711040.USD","LU1868836591.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU1093756325.SGD"],"gpt_icon":0},{"id":"2576044855","title":"Shares of Replimune Group Rise 75.8% Premarket After US FDA Accepts Resubmission for Potential Approval of Skin Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2576044855","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576044855?lang=en_us&edition=fundamental","pubTime":"2025-10-20 19:29","pubTimestamp":1760959770,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"26c657bd6894c690b20c7751c141e52e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nFWN3VZ0EW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["REPL","BK4139"],"gpt_icon":0},{"id":"2576885520","title":"Replimune Group Inc: Pdufa Date Set by FDA for Rp1 Is April 10, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2576885520","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576885520?lang=en_us&edition=fundamental","pubTime":"2025-10-20 19:01","pubTimestamp":1760958077,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nFWN3W009P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["REPL","BK4139"],"gpt_icon":0},{"id":"2576853466","title":"Replimune Announces FDA Acceptance of Bla Resubmission of Rp1 for the Treatment of Advanced Melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2576853466","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576853466?lang=en_us&edition=fundamental","pubTime":"2025-10-20 19:01","pubTimestamp":1760958077,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nFWN3W009P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["REPL","BK4139"],"gpt_icon":0},{"id":"2576853434","title":"FDA Accepts Replimune BLA Resubmission for RP1 in Advanced Melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2576853434","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576853434?lang=en_us&edition=fundamental","pubTime":"2025-10-20 19:00","pubTimestamp":1760958015,"startTime":"0","endTime":"0","summary":"Replimune Group Inc. announced that the U.S. Food and Drug Administration  has accepted the resubmission of its Biologics License Application  for RP1 in combination with nivolumab for the treatment of advanced melanoma in patients who have progressed on anti-PD-1 therapy. The FDA has set a Prescription Drug User Fee Act  target action date of April 10, 2026. The resubmission addresses previous agency feedback and is considered a complete response to the FDA's earlier complete response letter from July 2025. No other organizations are mentioned as recipients of this regulatory review.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Replimune Group Inc. published the original content used to generate this news brief via GlobeNewswire  on","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nNDL53xYq8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","LU2210149790.SGD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU0314104364.USD","REPL","BK4588","LU2210150020.SGD","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4112","NDAQ","BK4585","BK4139"],"gpt_icon":0},{"id":"2576105006","title":"Replimune announces new ad hoc analysis from IGNYTE phase 2 cohort of RP1","url":"https://stock-news.laohu8.com/highlight/detail?id=2576105006","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576105006?lang=en_us&edition=fundamental","pubTime":"2025-10-20 05:10","pubTimestamp":1760908206,"startTime":"0","endTime":"0","summary":"Replimune (REPL) Group announced data from a new ad hoc analysis from the IGNYTE phase 2 cohort of RP1 plus nivolumab was presented by Caroline Rob...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/replimune-announces-new-ad-hoc-analysis-from-ignyte-phase-2-cohort-of-rp1-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/replimune-announces-new-ad-hoc-analysis-from-ignyte-phase-2-cohort-of-rp1-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2576075211","title":"Replimune Reports 44% Response Rate for RP1 Plus Nivolumab in Acral Melanoma Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2576075211","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576075211?lang=en_us&edition=fundamental","pubTime":"2025-10-19 20:00","pubTimestamp":1760875214,"startTime":"0","endTime":"0","summary":"Replimune Group Inc. announced new data from an ad hoc analysis of the IGNYTE phase 2 cohort evaluating RP1 in combination with nivolumab in patients with acral melanoma. Results were presented at the European Society for Medical Oncology  Congress 2025. The analysis showed an objective response rate of 44%  and a median duration of response of 11.9 months. The combination therapy demonstrated a favorable safety profile, with most treatment-related adverse events being grade 1 or 2 and transient. Acral melanoma is a rare and aggressive skin cancer subtype that often responds poorly to available therapies. Replimune also noted that the IGNYTE-3 phase 3 trial, evaluating RP1 plus nivolumab versus physician's choice of treatment in melanoma patients who have progressed on anti-PD1 and anti-CTLA-4 therapy, is currently recruiting. Additionally, data on the efficacy and safety of RP1 plus nivolumab in non-melanoma skin cancers were presented at the same congress.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251019:nNDL44VykX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","NDAQ","LU2095319765.USD","BK4139","LU0314104364.USD","IE00B64PRP62.GBP","BK4112","IE00BGHQF748.EUR","LU2210149790.SGD","REPL","LU2210150020.SGD","IE00BKPKM429.USD","BK4585","BK4588"],"gpt_icon":0},{"id":"2576018539","title":"Replimune Group Inc. Releases Study Results on RP1 and Nivolumab Combination in Anti-PD-1 Resistant Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2576018539","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576018539?lang=en_us&edition=fundamental","pubTime":"2025-10-18 15:15","pubTimestamp":1760771719,"startTime":"0","endTime":"0","summary":"Replimune Group Inc. published a document detailing clinical trial data on the use of intratumoral RP1 in combination with nivolumab for patients with advanced or metastatic tumors, including information on patient response rates, dosing protocols, and resistance categories to anti-PD-1 therapy. The full document can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Replimune Group Inc. published the original content used to generate this news brief on October 18, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251018:nNDL9B7zx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2576018531","title":"Replimune Group Inc. publishes study on immunotherapy for non-melanoma skin cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2576018531","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576018531?lang=en_us&edition=fundamental","pubTime":"2025-10-18 15:15","pubTimestamp":1760771706,"startTime":"0","endTime":"0","summary":"Replimune Group Inc. published a document related to clinical research on non-melanoma skin cancers, including information on the ongoing IGNYTE study and patient enrollment. The document provides details about the study sponsor, trial contacts, and study context, as well as acknowledgments for medical writing support and trial participation. The full document can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Replimune Group Inc. published the original content used to generate this news brief on October 18, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251018:nNDLb4RDHp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2569983627","title":"Replimune Group (REPL) Receives a Hold from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2569983627","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569983627?lang=en_us&edition=fundamental","pubTime":"2025-09-23 15:55","pubTimestamp":1758614127,"startTime":"0","endTime":"0","summary":"Barclays analyst Peter Lawson maintained a Hold rating on Replimune Group today and set a price target of $3.00. The company’s shares closed yester...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/replimune-group-repl-receives-a-hold-from-barclays-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/replimune-group-repl-receives-a-hold-from-barclays-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2569003789","title":"Class Action Lawsuit Filed Against Replimune Group Inc. for Alleged Securities Fraud","url":"https://stock-news.laohu8.com/highlight/detail?id=2569003789","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569003789?lang=en_us&edition=fundamental","pubTime":"2025-09-22 19:37","pubTimestamp":1758541037,"startTime":"0","endTime":"0","summary":"A class action lawsuit has been filed against Replimune Group Inc., targeting alleged securities fraud that occurred between November 22, 2024, and July 21, 2025. The complaint claims that the company made false statements and concealed issues related to the IGNYTE trial's prospects, which the FDA later deemed inadequate and not well-controlled. This allegedly led to materially false and misleading representations about Replimune's business and operations. Investors who suffered financial losses during this period are represented in the lawsuit. The legal action is being managed by Levi & Korsinsky, a firm with a strong track record in securities litigation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Replimune Group Inc. published ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250922:nNDLb4YGbR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REPL","BK4139"],"gpt_icon":0},{"id":"2568576732","title":"JPMorgan Downgrades Replimune Group to Underweight From Neutral","url":"https://stock-news.laohu8.com/highlight/detail?id=2568576732","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568576732?lang=en_us&edition=fundamental","pubTime":"2025-09-19 19:14","pubTimestamp":1758280447,"startTime":"0","endTime":"0","summary":"Replimune Group (REPL) has an average rating of Hold and mean price target of $7.14, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["REPL","BK4139"],"gpt_icon":0},{"id":"2568252242","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Nektar Therapeutics (NKTR), Embecta Corporation (EMBC) and Replimune Group (REPL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2568252242","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568252242?lang=en_us&edition=fundamental","pubTime":"2025-09-19 18:40","pubTimestamp":1758278410,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Nektar Therapeutics (NKTR – Research Report), Embe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-nektar-therapeutics-nktr-embecta-corporation-embc-and-replimune-group-repl-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-nektar-therapeutics-nktr-embecta-corporation-embc-and-replimune-group-repl-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4198","HCSG","LABU","BK4007","BK4588","XBI","REPL","BK4585","EMBC","NKTR","BK4137","XLV","BK4139"],"gpt_icon":0},{"id":"2568725993","title":"J.P. Morgan Remains a Sell on Replimune Group (REPL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2568725993","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568725993?lang=en_us&edition=fundamental","pubTime":"2025-09-19 17:06","pubTimestamp":1758272765,"startTime":"0","endTime":"0","summary":"J.P. Morgan analyst Anupam Rama maintained a Sell rating on Replimune Group today. The company’s shares closed yesterday at $3.46. According to Tip...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-remains-a-sell-on-replimune-group-repl-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-remains-a-sell-on-replimune-group-repl-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["REPL","LU2089284900.SGD","LU0314104364.USD","LU1162221912.USD","LU1548497426.USD","BK4585","LU1732799900.SGD","LU0158827781.USD","LU0971096721.USD","LU2271345857.HKD","LU0795875169.SGD","BK4504","LU1989772840.SGD","LU2133065610.SGD","LU0225283273.USD","LU1074936037.SGD","LU2347655156.SGD","BK4127","LU0106831901.USD","LU1720051108.HKD","LU2023251221.USD","LU1720051017.SGD","BK4534","LU1989772923.USD","LU0158827948.USD","LU2028103732.USD","BK4516","LU0882574139.USD","LU1244550577.SGD","LU1244550221.USD","LU1668664300.SGD","LU2357305700.SGD","LU2111349929.HKD","BK4581","LU1363072403.SGD","IE00BKVL7J92.USD","LU0106261372.USD","LU0098860793.USD","BK4139","LU0234570918.USD","LU0006306889.USD","LU0267386448.USD","LU1732800096.USD","LU0912757837.SGD","BK4588","LU0320765646.SGD","LU1244550494.USD","LU2089283258.USD","LU0795875086.SGD","IE00BZ1G4Q59.USD"],"gpt_icon":0},{"id":"2568259998","title":"Replimune downgraded to Underweight from Neutral at JPMorgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2568259998","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568259998?lang=en_us&edition=fundamental","pubTime":"2025-09-19 17:05","pubTimestamp":1758272720,"startTime":"0","endTime":"0","summary":"JPMorgan downgraded Replimune (REPL) to Underweight from Neutral without a price target The regulatory path forward for RP1 is unclear and potentia...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/replimune-downgraded-to-underweight-from-neutral-at-jpmorgan-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/replimune-downgraded-to-underweight-from-neutral-at-jpmorgan-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0034235303.USD","LU0976567544.SGD","LU0689472784.USD","LU0211331839.USD","LU1363072403.SGD","IE0034235295.USD","IE00BDRTCR15.USD","BK4588","LU1280957306.USD","REPL","LU0323591593.USD","LU0106261372.USD","LU0267386448.USD","LU1244550577.SGD","LU2746668461.USD","LU1894683348.USD","LU2237443895.HKD","LU0211326755.USD","LU2237443549.SGD","IE00BWXC8680.SGD","LU0203345920.USD","IE00BZ1G4Q59.USD","LU1119994496.HKD","LU0203347892.USD","LU1551013342.USD","LU0256863811.USD","LU0345769631.USD","LU0320765489.SGD","LU1267930490.SGD","LU2023250504.SGD","IE00BLSP4452.SGD","LU2237443622.USD","LU1032466523.USD","LU2746668974.SGD","LU1548497426.USD","LU2756315664.SGD","LU0964807845.USD","LU0345769128.USD","LU1366192091.USD","LU2237443978.SGD","LU1720051108.HKD","LU2023250843.SGD","BK4550","LU0943347566.SGD","LU1894683264.USD","LU2357305700.SGD","LU0787776722.HKD","LU0211326839.USD","IE00BKDWB100.SGD","IE00BJTD4V19.USD"],"gpt_icon":0},{"id":"2568423091","title":"Replimune Group (REPL) Gets a Hold from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2568423091","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568423091?lang=en_us&edition=fundamental","pubTime":"2025-09-19 15:05","pubTimestamp":1758265516,"startTime":"0","endTime":"0","summary":"Barclays analyst Peter Lawson maintained a Hold rating on Replimune Group today and set a price target of $3.00. The company’s shares closed yester...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/replimune-group-repl-gets-a-hold-from-barclays-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/replimune-group-repl-gets-a-hold-from-barclays-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2568239710","title":"Replimune Group Inc : JP Morgan Cuts to Underweight From Neutral","url":"https://stock-news.laohu8.com/highlight/detail?id=2568239710","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568239710?lang=en_us&edition=fundamental","pubTime":"2025-09-19 12:38","pubTimestamp":1758256725,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250919:nFWN3V608T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["REPL","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":100,"code":"91000000","status":"200"}]}}